Tedaldi Gianluca, Molinari Chiara, São José Celina, Barbosa-Matos Rita, André Ana, Danesi Rita, Arcangeli Valentina, Ravegnani Mila, Saragoni Luca, Morgagni Paolo, Rebuzzi Francesca, Canale Matteo, Pignatta Sara, Ferracci Elisa, Martinelli Giovanni, Ranzani Guglielmina Nadia, Oliveira Carla, Calistri Daniele, Ulivi Paola
Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.
i3S, Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.
Pharmaceuticals (Basel). 2021 May 12;14(5):457. doi: 10.3390/ph14050457.
E-cadherin is a key player in gastric cancer (GC) and germline alterations of , its encoding gene, are responsible for Hereditary Diffuse Gastric Cancer (HDGC) syndrome. This study aimed at elucidating the role of genetic variants and DNA methylation of promoter and enhancers in the regulation of gene expression. For this purpose, we analyzed genetic variants of the gene through Next-Generation Sequencing (NGS) in a series of GC cell lines (NCI-N87, KATO-III, SNU-1, SNU-5, GK2, AKG, KKP) and the corresponding expression levels. By bisulfite genomic sequencing, we analyzed the methylation status of regulatory regions in 8 GC cell lines, in a series of 13 sporadic GC tissues and in a group of 20 HDGC -negative patients and 6 healthy controls. The NGS analysis on coding and regulatory regions detected genetic alterations in 3 out of 5 GC cell lines lacking functional E-cadherin. regulatory regions showed different methylation patterns in patients and controls, GC cell lines and GC tissues, expressing different E-cadherin levels. Our results showed that alterations in terms of genetic variants and DNA methylation patterns of both promoter and enhancers are associated with expression levels and have a role in its regulation.
E-钙黏蛋白是胃癌(GC)中的关键因子,其编码基因的种系改变是遗传性弥漫性胃癌(HDGC)综合征的病因。本研究旨在阐明基因变异以及启动子和增强子的DNA甲基化在基因表达调控中的作用。为此,我们通过新一代测序(NGS)分析了一系列胃癌细胞系(NCI-N87、KATO-III、SNU-1、SNU-5、GK2、AKG、KKP)中该基因的基因变异以及相应的表达水平。通过亚硫酸氢盐基因组测序,我们分析了8个胃癌细胞系、13个散发性胃癌组织以及20例HDGC阴性患者和6例健康对照中该基因调控区域的甲基化状态。对该基因编码区和调控区的NGS分析在5个缺乏功能性E-钙黏蛋白的胃癌细胞系中检测到3个存在基因改变。该基因调控区域在患者和对照、胃癌细胞系和胃癌组织中呈现出不同的甲基化模式,且E-钙黏蛋白表达水平也不同。我们的结果表明,启动子和增强子的基因变异及DNA甲基化模式改变均与E-钙黏蛋白表达水平相关,并在其调控中发挥作用。